Sparkling Tech Solutions, based in Canarias, is at the forefront of research for the early detection of neurodegenerative diseases like Alzheimer's. Driven by the personal experience of its co-founder, the company combines video games, artificial intelligence, and applied neuroscience to develop innovative tools.
Video games are a fundamental pillar of their methodology. Co-founder Maica Amador highlights their potential not just as entertainment, but also for their social and psychological value. By allowing users to play without feeling evaluated, valuable data is collected, which is then used to train artificial intelligence and identify unusual behaviors or risks associated with the early stages of these diseases.
Among their most notable projects is NeuroGlint, a platform that detects emotions through interaction in augmented and virtual reality environments. In parallel, they have developed Adaia, an emotional intelligence that acts as a virtual companion, offering guidance and advising users on the need to seek professional help when significant signs of intrusive negative emotions are detected.
Another relevant initiative is Little Challenge, which uses 2D and 3D video games for tablets, mobile phones, and computers. This project has a dual objective: to preserve the cultural heritage of Canarias and combat loneliness in the elderly, fostering intergenerational interaction. They collaborate with Alzheimer Canarias in Gran Canaria to apply these video games in the early stages of Alzheimer's.
The STAR-SAT project explores the potential link between atmospheric phenomena, such as dust storms and rain, and the increase in hospital visits by individuals with dementia or neurodegenerative diseases, using satellite imagery to analyze atmospheric variables and the behavior of vulnerable populations.
Sparkling Tech Solutions has received support from the public company Proexca for its internationalization efforts, participating in events like MyPINE 2025 in Tenerife and Málaga Transfiere, where they were recognized as a success story. The company also plans to attend MEDICA in Düsseldorf and has established links with universities and suppliers in China, aiming to materialize their AI into physical forms. The goal is to validate their hypotheses, pass ethical committee reviews, and commercialize their products in Canarias before expanding to other markets.
